Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: A prospective cohort study

Extended interval BNT162b2 vaccination enhances peak antibody generation

(2022) Helen Parry et al.   npj Vaccines

Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS‐CoV ‐2 infection*

(2022) Salma Sheikh‐Mohamed et al.   IMMUNOLOGICAL REVIEWS

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

(2021) Merryn Voysey et al.   LANCET

Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2

(2021) Romain Gasser et al.   Cell Reports

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects

(2021) Angela Huynh et al.   Viruses-Basel

Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?

(2021) Elena Pettini et al.   Vaccines

Human IgG and IgA responses to COVID-19 mRNA vaccines

(2021) Adam V. Wisnewski et al.   PLoS One

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

(2021) Rebecca P. Payne et al.   CELL

Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals

(2021) Brian Grunau et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antibody Responses 3-5 Months Post-Vaccination with mRNA-1273 or BNT163b2 in Nursing Home Residents

(2021) Jessica A. Breznik et al.   Journal of the American Medical Directors Association

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

(2021) Gayatri Amirthalingam et al.   Nature Communications

Innate and secondary humoral responses are improved by increasing the time between MVA vaccine immunizations

(2020) Jean-Louis Palgen et al.   npj Vaccines

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Factors That Influence the Immune Response to Vaccination

(2019) Petra Zimmermann et al.   CLINICAL MICROBIOLOGY REVIEWS

Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial

(2017) Lisa A. Jackson et al.   VACCINE

Strategies to guide the antibody affinity maturation process

(2015) Nicole A Doria-Rose et al.   Current Opinion in Virology

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario

(2013) Sharon E. Frey et al.   VACCINE